4D MOLECULAR THERAPEUTICS, INC.

(FDMT)
  Report
Delayed Nasdaq  -  05/20 04:00:00 pm EDT
7.810 USD   +5.97%
05/13SVB Securities Adjusts 4D Molecular Therapeutics' Price Target to $28 from $30, Keeps Outperform Rating
MT
05/124D MOLECULAR THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
05/124D Molecular Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 Technical AnalysisHistorical ChartNews ChartSector ChartComparison ChartReversed ChartRelative Strength Chart
Static chartExpert dynamic chartDynamic Chart 
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance10,212,616,2
Spread/Res.-24%-38%-52%
Spread/Supp.6,0%6,0%18%
Support7,377,376,61
Notations Surperformance© of 4D Molecular Therapeutics, Inc.  Help  
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes